AAM
AVNS

Azzad Asset Management’s Avanos Medical AVNS Stock Holding History

Azzad Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-43,230
Closed -$500K – 331
2025
Q3 		$500K Buy
43,230
+1,240
+3% +$14.5K 0.05% 287
2025
Q2 		$514K Buy
41,990
+951
+2% +$12K 0.06% 270
2025
Q1 		$588K Buy
41,039
+1,404
+4% +$21.9K 0.07% 257
2024
Q4 		$631K Buy
39,635
+10,930
+38% +$216K 0.12% 141
2024
Q3 		$690K Buy
28,705
+184
+0.6% +$4.21K 0.08% 256
2024
Q2 		$568K Buy
28,521
+2,223
+8% +$43.3K 0.07% 256
2024
Q1 		$524K Buy
26,298
+379
+1% +$7.33K 0.06% 268
2023
Q4 		$581K Sell
25,919
-2,474
-9% -$51.1K 0.07% 254
2023
Q3 		$574K Buy
28,393
+745
+3% +$16.9K 0.08% 254
2023
Q2 		$707K Buy
27,648
+6,589
+31% +$174K 0.09% 250
2023
Q1 		$626K Buy
21,059
+445
+2% +$12.9K 0.09% 256
2022
Q4 		$558K Buy
20,614
+67
+0.3% +$1.64K 0.09% 252
2022
Q3 		$448K Sell
20,547
-2,629
-11% -$68.7K 0.05% 349
2022
Q2 		$634K Buy
23,176
+3,317
+17% +$95.3K 0.06% 322
2022
Q1 		$665K Buy
19,859
+321
+2% +$10.3K 0.1% 249
2021
Q4 		$677K Sell
19,538
-255
-1% -$8.24K 0.09% 268
2021
Q3 		$618K Buy
+19,793
New +$672K 0.09% 276

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Azzad Asset Management's AVNS Position: Q4 2025 in Review

Azzad Asset Management sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 43,230 shares — an estimated $500K sold.

Azzad Asset Management first reported a position in AVNS in Q3 2021 and held it in 17 quarters. The position peaked at $707K in Q2 2023. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Azzad Asset Management reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • Azzad Asset Management sold 43,230 Avanos Medical shares in Q4 2025, an estimated $500K.
  • Azzad Asset Management first reported a position in Avanos Medical in Q3 2021 and held it in 17 quarters.
  • Azzad Asset Management's Avanos Medical position peaked at $707K in Q2 2023.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Azzad Asset Management's 13F filing for Q4 2025, filed 21 Jan 2026.